To conclude, we have shown that the combined use of OAV-Decorin and CAIX-CAR-T displayed synergistic antitumor effects in vitro and in vivo by enhancing T cell persistence, which led to prolonged survival of the tumor-bearing mice. The gene discussed is DCN; the disease is neoplasm.